Particulate Matter Air Pollution: Effects on the Cardiovascular System.

Hamanaka RB, Mutlu GM. · 2018

Read Particulate Matter Air Pollution: Effects on the Cardiovascular System. by Hamanaka RB, Mutlu GM. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6250783.txt.

Introduction

Hamanaka and Mutlu review how fine particle air pollution harms the heart and vessels. Their review appeared in Frontiers in Endocrinology. Air pollution mixes gases and tiny particles from many sources. Studies worldwide link it to more illness and death. Particles show stronger effects than the gas parts. Both short and long exposure raise risk.

Heart effects include blocked artery disease, heart failure, and stroke. Particles also act on hormone systems. They may help drive obesity and diabetes, which add heart risk on their own. Deaths from air pollution are expected to grow sharply by 2050. The authors set out the proof from population studies first. They then turn to how particles may damage tissue. Knowing those paths is key to cutting the harm.

Catalog record

CREATORHamanaka RB, Mutlu GM.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6250783

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Particulate Matter Air Pollution: Effects on the Cardiovascular System By Robert B. Hamanaka, Gökhan M. Mutlu Published in: Frontiers in Endocrinology DOI: 10.3389/fendo.2018.00680 ABSTRACT Air pollution is a complex mixture of gaseous and particulate components, each of which has detrimental effects on human health. While the composition of air pollution varies greatly depending on the source, studies from across the world have consistently shown that air pollution is an important modifiable risk factor for significantly increased morbidity and mortality. Moreover, clinical studies have generally shown a greater impact of particulate matter (PM) air pollution on health than the gaseous components. PM has wide-ranging deleterious effects on human health, particularly on the cardiovascular system. Both acute and chronic exposure to PM air pollution is associated with increased risk of death from cardiovascular diseases including ischemic heart disease, heart failure, and ischemic/thrombotic stroke. Particulate matter has also been shown to be an important endocrine disrupter, contributing to the development of metabolic diseases such as obesity and diabetes mellitus, which themselves are risk factors for cardiovascular disease. While the epidemiological evidence for the deleterious effects of PM air pollution on health is increasingly accepted, newer studies are shedding light on the mechanisms by which PM exerts its toxic effects. A greater understanding of how PM exerts toxic effects on human health is required in order to prevent and minimize the deleterious health effects of this ubiquitous environmental hazard. Air pollution is a growing public health problem and mortality due to air pollution is expected to double by 2050. Here, we review the epidemiological evidence for the cardiovascular effects of PM exposure and discuss current understanding about the biological mechanisms, by which PM exerts toxic effects on cardiovascular system to induce cardiovascular disease. INTRODUCTION Ambient air pollution is a growing global health problem estimated to contribute to as many as 3.1 million all-cause deaths per year (1–3). Exposure to air pollution is the largest environmental health risk and ranks ninth among modifiable disease risk factors, above other common factors such as low physical activity, high cholesterol, and drug use (2). Most of the excess deaths attributable to air pollution exposure are due to acute ischemic/thrombotic cardiovascular events. In addition to excess mortality, air pollution is associated with significant reductions in healthy life years and worker productivity (2, 4). Air pollution may also be an important endocrine disrupter, contributing to the development of metabolic diseases such as obesity and diabetes mellitus (5). While the developing world is most burdened by air pollution-associated health effects, the association between air pollution and mortality is still evident in developed countries where pollution levels are well below target standards (6, 7). The purpose of this article is (1) to introduce the reader to the major studies that have established the link between particulate matter (PM) air pollution and human cardiovascular and metabolic disease and (2) to discuss the mechanisms by which PM mediates its biologic effects. For systematic review of the connection between air pollution and human disease, we refer the reader to several recent systematic reviews and meta-analyses (8–14). AIR POLLUTION Air pollution is a complex mixture of gaseous and particulate components, each of which has detrimental effects on cardiovascular and respiratory systems. The composition of air pollution varies greatly, depending on the source, emission rate, and sunlight and wind conditions. Gaseous components of air pollution include nitrogen dioxide (NO2), nitric oxide (NO), sulfur dioxide (SO2), ozone (O3), and carbon monoxide (CO) (2, 15, 16). Particulate matter (PM) components of air pollution consist of carbonaceous particles with associated adsorbed organic chemicals and reactive metals. Common components of PM include nitrates, sulfates, polycyclic aromatic hydrocarbons, endotoxin, and metals such as iron, copper, nickel, zinc, and vanadium (2, 15, 17). PM is subclassified according to particle size into (a) coarse (PM10, diameter <10μm), (b) fine (PM2.5, diameter <2.5μm), and (c) ultrafine (PM0.1, diameter <0.1μm). Coarse particles derive from numerous natural and industrial sources and generally do not penetrate beyond the upper bronchus. Fine and ultrafine particles are produced through the combustion of fossil fuels and represent a greater threat to health than coarse particles as they penetrate into the small airways and alveoli (16–19). While the organic and metal components of particles vary with location, levels of PM2.5 have consistently correlated with negative cardiovascular outcomes regardless of location (15). EPIDEMIOLOGICAL STUDIES LINKING PM EXPOSURE TO MORBIDITY AND MORTALITY IN HUMANS The association between high levels of PM air pollution and adverse health outcomes has been known since the first half of the twentieth century. Smog incidents in Meuse Valley, Belgium (1930), Donora, Pennsylvania (1948), and London, UK (1952) acutely caused increased hospitalizations and deaths, particularly in the elderly and those with preexisting cardiac and respiratory diseases. An estimated 4,000 people died as a direct result of the London smog with 100,000 more suffering adverse health effects (20, 21). These incidents resulted in policy changes including the implementation of Clean Air Act in 1970 (22). The reduction in PM levels have led to gradual reduction in PM-associated morbidity and mortality; however, recent epidemiologic studies still consistently show a link between PM exposure and cardiopulmonary mortality. Short-term exposure studies The increased deaths due to the smog in Meuse Valley, Donora, and London clearly suggested that acute exposure to air pollution is associated with adverse health outcomes. These classic cases of air pollution-induced mortality represent extreme examples, with the London smog reaching air PM concentrations of 4.5 mg/m3 (World Health Organization current safety guideline is 25 μg/m3) (21). A large number of short-term exposure studies have evaluated the associations between less extreme levels of air pollution and daily changes in mortality (15, 18). A recent meta-analysis of 110 peer-reviewed studies revealed that every 10 μg/cm3 increase in PM2.5 concentration was associated with a 1.04% (95% CI 0.52%-1.56%) increase in all-cause mortality (10). Hospitalizations and mortality due to cardiovascular and respiratory illnesses were positively correlated with increases in PM2.5 concentrations. Several large, multi-city studies have been conducted in both North America and Europe, the largest being the NMMAPS (National Morbidity, Mortality, and Air Pollution Study) (23–25) and APHEA (Air Pollution and Health: A European Approach) (26, 27) studies. Findings from these studies were remarkably consistent and demonstrated that PM levels are significantly associated with daily all-cause, cardiovascular, and pulmonary mortality. Seasonal and regional variations existed in both studies possibly attributable to different sources of pollutants, meteorological conditions, and population differences. For example, the APHEA study found a stronger effect of PM on daily mortality in cities with a larger contribution of traffic emissions to total PM. This is in agreement with a recent study on triggers of myocardial infarction (MI) in which traffic exposure was found to be as significant of a trigger of MI as physical exertion and alcohol use (28). The NMMAPS study also found that the relationship between PM exposure and mortality was independent of gaseous co-pollutants, including NO2, CO, and SO2. Studies carried out in Asia and the developing world have generally shown smaller effects on daily mortality due to PM than studies from the United States and Europe. A recent meta-analysis of 85 studies from 12 low- and middle-income countries showed a 0.47% (95% CI 0.34-0.61) increase for cardiovascular

Read the complete text